Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Astera Labs Inc (NASDAQ: ALAB) closed the day trading at $186.43 up 0.31% from the previous closing price of $185.85. In other words, the price has increased by $0.31 from its previous closing price. On the day, 4.7 million shares were traded. ALAB stock price reached its highest trading level at $187.18 during the session, while it also had its lowest trading level at $176.0.
Ratios:
For a better understanding of ALAB, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 147.30. For the most recent quarter (mrq), Quick Ratio is recorded 10.55 and its Current Ratio is at 11.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On May 16, 2025, Susquehanna started tracking the stock assigning a Neutral rating and target price of $80.Susquehanna initiated its Neutral rating on May 16, 2025, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’25 when Tate Michael Truett sold 100,000 shares for $191.19 per share. The transaction valued at 19,118,988 led to the insider holds 401,496 shares of the business.
TATE 1997 LIVING TRUST bought 100,000 shares of ALAB for $19,118,990 on Aug 12 ’25. On Aug 08 ’25, another insider, Dyckerhoff Stefan A, who serves as the Director of the company, sold 25,000 shares for $175.26 each. As a result, the insider received 4,381,478 and left with 74,154 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 30988208128 and an Enterprise Value of 29955454976. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 326.90, and their Forward P/E ratio for the next fiscal year is 93.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 51.17 while its Price-to-Book (P/B) ratio in mrq is 27.28. Its current Enterprise Value per Revenue stands at 49.468 whereas that against EBITDA is 642.173.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.48, which has changed by 3.760725 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $199.47, while it has fallen to a 52-week low of $36.85. The 50-Day Moving Average of the stock is 59.04%, while the 200-Day Moving Average is calculated to be 90.30%.
Shares Statistics:
Over the past 3-months, ALAB traded about 5.33M shares per day on average, while over the past 10 days, ALAB traded about 7004020 shares per day. A total of 166.21M shares are outstanding, with a floating share count of 126.62M. Insiders hold about 23.87% of the company’s shares, while institutions hold 61.05% stake in the company. Shares short for ALAB as of 1753920000 were 9280319 with a Short Ratio of 1.74, compared to 1751241600 on 11029405. Therefore, it implies a Short% of Shares Outstanding of 9280319 and a Short% of Float of 7.59.
Earnings Estimates
The stock of Astera Labs Inc (ALAB) is currently drawing attention from 12.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.42, with high estimates of $0.46 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.62 and $1.55 for the fiscal current year, implying an average EPS of $1.59. EPS for the following year is $2.0, with 13.0 analysts recommending between $2.33 and $1.8.
Revenue Estimates
11 analysts predict $206.23M in revenue for the current quarter. It ranges from a high estimate of $207.9M to a low estimate of $201.52M. As of the current estimate, Astera Labs Inc’s year-ago sales were $113.09MFor the next quarter, 11 analysts are estimating revenue of $216.38M. There is a high estimate of $222.3M for the next quarter, whereas the lowest estimate is $209.58M.
A total of 13 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $805M, while the lowest revenue estimate was $762.47M, resulting in an average revenue estimate of $776.84M. In the same quarter a year ago, actual revenue was $396.29MBased on 13 analysts’ estimates, the company’s revenue will be $1.02B in the next fiscal year. The high estimate is $1.15B and the low estimate is $971.85M.
